Advertisement

High Prevalence of HCV Infection in Patients with Oral Cancer and Oral Precancerous Lesion

  • Michio Sata
  • Yumiko Nagao
  • Tadamitsu Kameyama
  • Kyuichi Tanikawa

Abstract

Hepatitis C virus (HCV) leads to serious consequences such as liver cirrhosis and hepatocellular carcinoma. Other than liver disease, HCV infection is associated with various extrahepatic manifestations and immunological disorders which include membranoproliferative glomerulonephritis, cryoglobulinemia, autoimmune thyroiditis, Sjögren syndrome, malignant lymphoma, and lichen planus [1–3]. Many authors have reported a relationship between pathogenesis of lichen planus and HCV infection [4–6]. We reported evidence of the high prevalence of HCV infection in patients with oral cancer or oral lichen planus (OLP) [7–18].

Keywords

Oral Cancer Lichen Planus Membranoproliferative Glomerulonephritis Oral Cancer Patient Oral Lichen Planus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Johnson RJ, Gretch DR, Yamabe H, et al (1993) Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328:465–470PubMedCrossRefGoogle Scholar
  2. 2.
    Gumber SC, Chopra S (1995) Hepatitis C: a multifaced disease. Ann Intern Med 123:615–620PubMedGoogle Scholar
  3. 3.
    Ferric C, Civita LL, Monti M, et al (1995) Can type C hepatitis infection be complicated by malignant lymphoma? Lancet 346:1426–1427CrossRefGoogle Scholar
  4. 4.
    Jubert C, Pawlotsky JM, Pouget F, et al (1994) Lichen planus and hepatitis C virus-related chronic active hepatitis. Arch Dermatol 130:73–76PubMedCrossRefGoogle Scholar
  5. 5.
    Gandolfo S, Carbone M, Carrozzo M, Gallo V (1994) Oral lichen planus and hepatitis C virus (HCV) infection: is there a relationship? A report of 10 cases. J Oral Pathol Med 23:119–122PubMedCrossRefGoogle Scholar
  6. 6.
    Carrozzo M, Gandolfo S, Carbone M, et al (1996) Hepatitis C virus infection in Italian patients with oral lichen planus: a prospective case-control study. J Oral Pathol Med 25:527–533PubMedCrossRefGoogle Scholar
  7. 7.
    Nagao Y, Sata M, Tanikawa K, Itoh K, Kameyama T (1995) High prevalence of hepatitis C virus antibody and RNA in patients with oral cancer. J Oral Pathol Med 24:354–360PubMedCrossRefGoogle Scholar
  8. 8.
    Nagao Y, Sata M, Tanikawa K, Itoh K, Kameyama T (1995) Lichen planus and hepatitis C virus in the Northern Kyushu region of Japan. Eur J Clin Invest 25:910–914PubMedCrossRefGoogle Scholar
  9. 9.
    Nagao Y, Sata M, Tanikawa K, Kameyama T (1995) A case of oral lichen planus with chronic hepatitis C successfully treated by glycyrrhizin. J J A Infect Dis 69:940–943Google Scholar
  10. 10.
    Nagao Y, Sata M, Fukuizumi K, Harada H, Kameyama T (1996) Oral cancer and hepatitis C virus (HCV): can HCV alone cause oral cancer? A case report. Kurume Med J 43:97–100PubMedCrossRefGoogle Scholar
  11. 11.
    Nagao Y, Sata M, Itoh K, Tanikawa K, Kameyama T (1996) Quantitative analysis of HCV RNA and genotype in patients with chronic hepatitis C accompanied by oral lichen planus. Eur J Clin Invest 26:495–498PubMedCrossRefGoogle Scholar
  12. 12.
    Nagao Y, Sata M, Suzuki H, Tanikawa K, Itoh K, Kameyama T (1996) Effectiveness of glycyrrhizin for oral lichen planus in patients with chronic HCV infection. J Gastroenterol 31:691–695PubMedCrossRefGoogle Scholar
  13. 13.
    Nagao Y, Sata M, Ide T, et al (1996) Development and exacerbation of oral lichen planus during and after interferon therapy for hepatitis C. Eur J Clin Invest 26:1171–1174PubMedCrossRefGoogle Scholar
  14. 14.
    Nagao Y, Sata M, Tanikawa K, Kameyama T (1997) Immunological evaluation in oral lichen planus with chronic hepatitis C. J Gastroenterol 32:324–329PubMedCrossRefGoogle Scholar
  15. 15.
    Nagao Y, Sata M, Itoh K, et al (1997) High prevalence of hepatitis C virus antibody and RNA in patients with head and neck squamous cell carcinoma. Hepatol Res 7:206–211Google Scholar
  16. 16.
    Nagao Y, Sata M, Fukuizumi K, Tanikawa K, Kameyama T (1997) High incidence of oral precancerous lesions in a hyperendemic area of hepatitis C virus infection. Hepatol Res 8:173–177CrossRefGoogle Scholar
  17. 17.
    Nagao Y, Sata M, Kameyama T (1998) Hepatitis C virus RNA detection in oral lichen planus tissue. Am J Gastroenterol 93:850PubMedCrossRefGoogle Scholar
  18. 18.
    Yoshida M, Nagao Y, Sata M, Kusukawa J, Kameyma T (1998) Multiple primary neoplasms and HCV infection in oral cancer patients. Hepatol Res: in pressGoogle Scholar
  19. 19.
    Yamakawa Y, Sata M, Suzuki H, Noguchi S, Tanikawa K (1996) Higher elimination rate of hepatitis C virus among women. J Viral Hepatitis 3:317–321CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 1999

Authors and Affiliations

  • Michio Sata
    • 1
  • Yumiko Nagao
    • 2
  • Tadamitsu Kameyama
    • 2
  • Kyuichi Tanikawa
    • 1
  1. 1.Second Department of MedicineKurume University School of MedicineKurume, FukuokaJapan
  2. 2.Department of Oral SurgeryKurume University School of MedicineKurume, FukuokaJapan

Personalised recommendations